The impact of subchronic lead poisoning on the vascular effect of nitric oxide in rats

Environmental Toxicology and Pharmacology

Volumn 19, Issue 1, 2005, Pages 99-106

  Skoczynska, Anna ^a   Stojek, Ewa ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Lead; Mesenteric bed; Nitric oxide; Rats

Indexed keywords

ACETYLCHOLINE; ARGININE; DRINKING WATER; LEAD; NITRIC OXIDE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERTENSION; LEAD BLOOD LEVEL; LEAD POISONING; MALE; MESENTERY BLOOD FLOW; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASOCONSTRICTION;

BUBALUS; RATTUS NORVEGICUS;

EID: 10044220732     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2004.05.004     Document Type: Article

References (24)

1. Boscolo P., Carmignani M., Carelli G., Finelli V.N., Giuliano G. Zinc and copper in tissues of rats with blood hypertension induced by long-term lead exposure. Toxicol. Lett. 63:1992;135
2. Buvinic S., Huidobro-Toro J.P. Basal tonic release of nitric oxide coupled to cGMP production regulates the vascular reactivity of the mesenteric bed. Eur. J. Pharmacol. 424:2001;221
3. Carmignani M., Volpe A.R., Boscolo P., Qiao N., Gioacchino M., Grilli A., Felaco M. Catecholamine and nitric oxide systems as targets of chronic lead exposure in inducing selective functional impairment. Life Sci. 68:2000;401
4. Chang H.R., Lee R.P., Wu C.Y., Chen H.I. Nitric oxide in mesenteric vascular reactivity: a comparison between rats with normotension and hypertension. Clin. Exp. Pharmacol. Physiol. 29:2002;275
5. Ding Y., Vaziri N.D., Gonick H.C. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ. Res. 76:1998;107
6. Gonick H.C., Ding Y., Bondy S.C., Ni Z., Vaziri N.D. Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species. Hypertension. 30:1997;1487
7. Harlan W.R. The relationship of blood lead levels to blood pressure in the US population. Environ. Health Perspect. 78:1988;9
8. Ignarro L.J. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol. 53:2002;503
9. Khalil-Manesh F., Gonick H.C., Weiler E.W., Prins B., Weber M.A., Purdy R.E. Lead-induced hypertension: possible role of endothelial factors. Am. J. Hypertens. 6:1993;723
10. Marquez M., Millas I., Jiminez A., Garcia-Colis E., Rodrigez-Feo J.A., Velasco S., Barrientos A., Casado S., Lopez-Farre A. Alteration of the soluble guanyle cyclase system in the vascular wall of lead-induced hypertension in rats. J. Am. Soc. Nephrol. 12:2001;2594
11. Purdy R.E., Smith J.R., Ding Y. Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am. J. Hypertens. 10:1997;997
12. Ralevic V. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed. Br. J. Pharmacol. 137:2002;19
13. Skoczynska A., Juzwa W., Smolik R., Szechiñski J., Běhal F. Response of the cardiovascular system to catecholamines in rats given small doses of lead. Toxicology. 39:1986;275
14. Skoczynska A., Smolik R., Jeleñ M. Lipid abnormalities in rats given small doses of lead. Arch. Toxicol. 67:1993;200
15. Skoczynska A., Wróbel J., Andrzejak R. Lead-cadmium interaction effect on the responsiveness of rat mesenteric vessels to norepinephrine and angiotensin II. Toxicology. 162:2001;157
16. Skoczynska A., Stojek E., Górecka H., Wojakowska A. The serum vasoactive agents in lead-treated rats. Int. J. Occup. Med. Environ. Health. 16:2003;169
17. Vaziri N.D., Ding Y., Ni Z., Gonick H.C. Altered nitric oxide metabolism and increased oxygen free radicals activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Internation. 52:1997;1042
18. Vaziri N.D., Ding Y., Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension. 34:1999;558
19. Vaziri N.D., Liang K., Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Internation. 56:1999;1492
20. Vaziri N.D., Ding Y., Ni Z. Compensatory up-regulation of nitric oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J. Pharmacol. Exp. Ther. 298:2001;679
21. Victery W. Evidence for effects of chronic lead exposure on blood pressure in experimental animals: an overview. Environ. Health Perspect. 78:1988;71
22. + channel blockers and herbimycin of acetylcholine- and flow-evoked vasodilatation in rat mesenteric small arteries. Br. J. Pharmacol. 138:2003;1562
23. Tsao D., Yu H.S., Cheng J.T., Ho C.K., Chang H.R. The change of beta-adrenergic system in lead-induced hypertension. Toxicol. Appl. Pharmacol. 164:2000;127
24. Watts S.W., Chai S., Webb R.C. Lead-acetate induced contraction in rabbit mesenteric artery: interaction with calcium and protein kinase C. Toxicology. 99:1995;55